We are live on
!
Find out more
Pfizer
PFE
PFE
2,049 hedge funds and large institutions have $141B invested in Pfizer in 2017 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 814 increasing their positions, 911 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.97% less ownership
Funds ownership: 74.86% → 73.89% (-0.97%)
3% less capital invested
Capital invested by funds: $145B → $141B (-$4.15B)
3% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 86
1% less funds holding
Funds holding: 2,074 → 2,049 (-25)
9% less funds holding in top 10
Funds holding in top 10: 180 → 164 (-16)
11% less repeat investments, than reductions
Existing positions increased: 814 | Existing positions reduced: 911
12% less call options, than puts
Call options by funds: $1.09B | Put options by funds: $1.24B
Holders
2,049
Holders Change
-25
Holders Change %
-1.21%
% of All Funds
51.08%
Holding in Top 10
164
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-8.89%
% of All Funds
4.09%
New
83
Increased
814
Reduced
911
Closed
86
Calls
$1.09B
Puts
$1.24B
Net Calls
-$144M
Net Calls Change
+$358M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$454M |
| 2 |
Lazard Asset Management
New York
|
-$415M |
| 3 |
CWM
CIBC World Markets
New York
|
-$368M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$325M |
| 5 |
Bank of New York Mellon
New York
|
-$193M |
